is bpc 157 fda approved status 2025 BPC-157 Approval Status: It for Human Use? bpc-157 fda status 2025 or

Description

However, recent FDA actions on BPC-157 and other peptides have sent shockwaves through the peptide community

Batch: GF-BPC10-B241 Key analytical results include: Assay Content: 10.71 mg Identification Retention Time: 0.998 Identification Spectrum: 996 Purity: greater than 99.8 percent Bacterial Endotoxins: 0.0120 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium

47 If BPC-157 ramps up EGR-1 in the wrong context, it could lead to overly aggressive tissue regrowth (like scar overgrowth or calcification in blood vessels)